Cabot (NYSE:CBT) Issues FY 2026 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.000-6.50 for the period, compared to the consensus EPS estimate of 6.240. The company issued revenue guidance of -.

Cabot Stock Up 4.1%

NYSE:CBT opened at $78.97 on Wednesday. The firm has a market capitalization of $4.12 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 10.00 and a beta of 0.78. Cabot has a 1-year low of $58.33 and a 1-year high of $83.71. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. The business’s fifty day moving average price is $73.67 and its 200 day moving average price is $70.26.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.14. The firm had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. Cabot had a return on equity of 22.82% and a net margin of 8.62%.Cabot’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, sell-side analysts forecast that Cabot will post 6.27 earnings per share for the current fiscal year.

Cabot Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be paid a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.4%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend is Friday, May 29th. Cabot’s dividend payout ratio (DPR) is currently 31.52%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on CBT shares. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price target on shares of Cabot in a research note on Wednesday, February 4th. UBS Group upped their price target on shares of Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Mizuho set a $75.00 target price on shares of Cabot and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $73.75.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Global Retirement Partners LLC lifted its stake in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares during the period. Danske Bank A S bought a new position in Cabot during the third quarter worth about $38,000. Geneos Wealth Management Inc. lifted its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Caitong International Asset Management Co. Ltd lifted its stake in Cabot by 709.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock worth $41,000 after purchasing an additional 468 shares during the period. Finally, Advisory Services Network LLC bought a new position in Cabot during the third quarter worth about $57,000. Institutional investors own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.